光动力疗法
光毒性
光敏剂
活性氧
细胞代谢
阳光
癌症研究
材料科学
纳米技术
新陈代谢
医学
化学
细胞生物学
光化学
生物
生物化学
体外
内科学
光学
物理
有机化学
作者
Haiyang Zhang,Jipeng Li,Yongqiang Li,Kexin Tan,Hang Wang,Muyue Yang,Yahan Ju,Yan Liu,Gang Wang,Xuefei Song,Ping Gu,Xiaoming Xie,Siwei Yang,Guqiao Ding,Huifang Zhou,Xianqun Fan
标识
DOI:10.1002/adfm.202414817
摘要
Abstract Phototoxicity poses a substantial challenge in photodynamic therapy, resulting in intolerable skin damage, visual impairment, and reduced quality of life. Current coping strategies, primarily focus on avoiding inappropriate photoactivation and developing targeted photosensitizers, have not effectively addressed this problem. Hence, this study aims to develop a “sunlight‐friendly” photodynamic therapy strategy. Here, 1‐methoxyphenazine methosulfate (MPMS) is innovatively identified as a key substance in achieving modified oxygen metabolism. MPMS demonstrates efficient catalytic shuttling under abnormal intracellular H2O2 levels, introducing a novel protective approach for oxygen metabolism and numerous life processes. By controlling MPMS administration, the switch of the photosensitizer states between “ON” (killing tumor cells) and “OFF” (safeguarding normal cells) can be achieved. This approach effectively mitigated phototoxicity and holds the potential for widespread clinical application.
科研通智能强力驱动
Strongly Powered by AbleSci AI